AvePoint (AvePoint) Research & Development : $36.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is AvePoint Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. AvePoint's Research & Development for the three months ended in Dec. 2023 was $9.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $36.3 Mil.

AvePoint Research & Development Historical Data

The historical data trend for AvePoint's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AvePoint Research & Development Chart

AvePoint Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

11.15

12.20

32.14

31.36

36.34

AvePoint Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial										7.51	9.02	9.27	8.64	9.41

AvePoint Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $36.3 Mil.

AvePoint (NAS:AVPT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

AvePoint Research & Development Related Terms

Thank you for viewing the detailed overview of AvePoint's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

AvePoint (AvePoint) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » AvePoint Inc (NAS:AVPT) » Definitions » Research & Development

Comparable Companies

CLBT ODD CSGS VRNT SWI NTCT STER GB ZUO AVDX MSFT ORCL ADBE PANW SNPS VMW FTNT CRWD PLTR SQ

Traded in Other Exchanges

N/A

Address

525 Washington Boulevard, Suite 1400, Jersey City, NJ, USA, 07310

Website

https://www.avepoint.com

AvePoint Inc is a Microsoft 365 data management solutions provider, offering a full suite of SaaS solutions to migrate, manage and protect data. Its products include Cloud Products, Hybrid Products; and solutions include Data Protection, Operational Governance, Records & Information Management, Microsoft Teams, SharePoint Online, Exchange Online, OneDrive for Business, Project Online, Planner, Yammer, and Public Folders.

Executives

Brian Michael Brown	director, officer: COO and General Counsel	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY NJ 07310
Sixth Street Partners Management Company, L.p.	10 percent owner	C/O SIXTH STREET PARTNERS, LLC, 2100 MCKINNEY AVENUE, SUITE 1500, DALLAS TX 75201
Alan Waxman	10 percent owner	C/O SIXTH STREET PARTNERS, LLC, 345 CALIFORNIA STREET, SUITE 2600, SAN FRANCISCO CA 94104
Janet Schijns	director	901 E BYRD STREET, SUITE 900, LEGAL DEPARTMENT, RICHMOND VA 23219
Sophia Wu	officer: Chief Financial Officer	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY NJ 07310
Tianyi Jiang	director, officer: Chief Executive Officer	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY NJ 07310
Xunkai Gong	director, 10 percent owner, other: Executive Chairman	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY NJ 07310
James Caci	officer: Chief Financial Officer	C/O AVEPOINT, INC., 525 WASHINGTON BLVD., SUITE 1400, JERSEY CITY NJ 07310
Zhijian Lu	10 percent owner	C/O AVEPOINT, INC., 525 WASHINGTON BLVD, SUITE 1400, JERSEY CITY NJ 07310
Ho John Chi On	director	C/O JANCHOR PARTNERS, ONE EXCHANGE SQUARE, CENTRAL K3 1608
Jeff Teper	director	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY NJ 07310
Andy Yong	officer: Chief Investment Officer	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY NJ 07310
Stephen Cuunjieng	director	1155 KAS DRIVE SUITE 100, RICHARDSON TX 75081
David K Chao	director	2420 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Peter W Bell	director